# Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer

> **NCT07656766** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Advanced Colorectal Cancer

## Interventions

- **DRUG:** Sintilimab
- **DRUG:** Gossypol Acetate

## Key facts

- **NCT ID:** NCT07656766
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2027-09-15
- **Final completion:** 2029-09-15
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07656766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07656766, "Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07656766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*